Company / EPS (Basic)
Day One Biopharmaceuticals, Inc. EPS (Basic) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$2.37
FY2025
5-year range
-$4.62 / -$2.17
FY2021-FY2025
Trend
-9.2%
vs FY2024
Sector context
#137 of 208
Health Care
What the data says
At $-2.37, Day One Biopharmaceuticals, Inc.'s eps (basic) ranks #137 of 208 in the Health Care sector. EPS (Basic) has fluctuated over the past 6 years, ranging from $-7.33 in FY2020 to $-2.17 in FY2024.
Based on SEC 10-K filings.
-2.37 in FY2025.
Remained stable around $-2.37 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#137 of 208 in Health CareTop 66% of 208This company -$2.37 Sector average -$1.02
▼
-133.2% below sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 9.2% year-over-year.
- Ranks #137 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2024.
- Lowest eps (basic) in the period was in FY2020.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.37 | -9.2% |
| FY2024 | -$2.17 | +8.4% |
| FY2023 | -$2.37 | -9.2% |
| FY2022 | -$2.17 | +53.0% |
| FY2021 | -$4.62 | +37.0% |
| FY2020 | -$7.33 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026